BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8273607)

  • 1. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images.
    Wheeler AL; Truwit CL; Kleinschmidt-DeMasters BK; Byrne WR; Hannon RN
    AJR Am J Roentgenol; 1993 Nov; 161(5):1049-51. PubMed ID: 8273607
    [No Abstract]   [Full Text] [Related]  

  • 2. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
    Kleinman PK; Ragland RL
    AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
    [No Abstract]   [Full Text] [Related]  

  • 3. Unusual MRI and pathologic findings of progressive multifocal leukoencephalopathy complicating adult Wiskott-Aldrich syndrome.
    Matsushima T; Nakamura K; Oka T; Tachikawa N; Sata T; Murayama S; Nukina N; Kanazawa I
    Neurology; 1997 Jan; 48(1):279-82. PubMed ID: 9008537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement.
    Gabata T; Matsui O; Kadoya M; Yoshikawa J; Miyayama S; Takashima T; Nagakawa T; Kayahara M; Nonomura A
    Radiology; 1994 Dec; 193(3):683-8. PubMed ID: 7972808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraosseous meningioma: CT and MR appearance.
    Lee HY; Prager J; Hahn Y; Ramsey RG
    J Comput Assist Tomogr; 1992; 16(6):1000-1. PubMed ID: 1430425
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
    Kransdorf MJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 10. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 12. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
    Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H
    Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
    Ito K; Mitchell DG; Honjo K; Fujita T; Awaya H; Takano K; Koike S; Matsumoto T; Matsunaga N
    AJR Am J Roentgenol; 1996 Nov; 167(5):1147-51. PubMed ID: 8911169
    [No Abstract]   [Full Text] [Related]  

  • 14. Superiority of magnetic resonance over computed tomography for imaging parotid tumor.
    Barsotti JB; Westesson PL; Coniglio JU
    Ann Otol Rhinol Laryngol; 1994 Sep; 103(9):737-40. PubMed ID: 8085738
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of ureteropelvic junction obstruction.
    Prasad PV; Hall FM
    AJR Am J Roentgenol; 1997 Oct; 169(4):1196-7. PubMed ID: 9308495
    [No Abstract]   [Full Text] [Related]  

  • 18. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
    Elster AD
    AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
    Semelka RC; Kroeker MA; Shoenut JP; Kroeker R; Yaffe CS; Micflikier AB
    Radiology; 1991 Dec; 181(3):785-91. PubMed ID: 1947098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R; Melloni P
    AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.